Scoat Pharma | Pellet Manufacturing & Research

Research & Development

Driving pharmaceutical innovation through advanced formulation technologies and customized pellet development.

Manufacturing

Utilizing state-of-the-art facilities to deliver high-capacity production of custom immediate and modified-release pellets.

Our Strategy

Maximizing production efficiency through advanced facilities while maintaining deep custom-formulation flexibility.

Global Compliance

Meeting rigorous international regulatory requirements to ensure absolute quality, safety, and trust. safety, and trust.

About Us

Incorporated in 2006, Scoat Pharma is a trusted symbol in developing, manufacturing, and exporting premium pharmaceutical pellets, co-promoted by Suraksha Group.

We specialize in customized manufacturing of Immediate Release, Modified Release, Enteric Coated Pellets, and Retard Micro Granules inside our state-of-the-art facility.

2025 Milestone: Relocated to a highly advanced facility maximizing production output and expanding our reach across global markets.

More details →

Why Scoat Pharma

Delivering excellence in pharmaceutical pellet development with decades of expertise and uncompromised quality standards.

State-Of-The-Art Facility

World-Class Manufacturing Standards

Decades of Expertise

Leading Pellets Manufacturer for over 2 decades, bringing deep domain excellence.

Wide Range of Product

Comprehensive options across Immediate, Modified, Enteric Coated Pellets & Granules.

WHO – GMP Standard

Ensuring rigorous quality standards fully matching WHO – GMP certifications.

On-Time Delivery

100% responsibility and committed timeliness across all product supplies.

Full Technical & Compliance Support

End-to-end Technical, Regulatory, and Compliance support dedicated to customer growth.

0 +

Customers

0 +

Countries

0 +

People

0 +

API's

Manufacturing Sites